Search Results

You are looking at 41 - 50 of 125 items for :

  • "genetic counseling" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Caiqian Cropper, Ashley Woodson, Banu Arun, Carlos Barcenas, Jennifer Litton, Sarah Noblin, Diane Liu, Minjeong Park, and Molly Daniels

counseling at our institution between March 31, 2013, and June 30, 2014. Because of the rarity of male breast cancer, all male patients with breast cancer seen for genetic counseling were included (genetic testing dates ranged from September 9, 1999–June 30

Full access

SSR-PET/MRI.” • “Well-Differentiated Grade 1/2” was added to page headings where applicable. • Testing for inherited genetic syndromes was revised: Genetic counseling and testing for inherited genetic syndromes. Neuroendocrine Tumors, Well

Full access

Wylie Burke and Nancy Press

. Neslon RM Botlikn JR Kodish ED . Ethical issues with genetic testing in pediatrics . Pediatrics 2001 ; 107 : 1451 – 1455 31. Wagner TM Moslinger R Langbauer G . Attitude towards prophylactic surgery and effects of genetic counselling in

Full access

Elizabeth Danielson

Benefits and Resource Guide will also address issues relevant for employees dealing with a loved one's cancer, including the impact of taking on a caregiver role, cancer risk reduction, recommended cancer screening, and understanding when genetic counseling

Full access

Margaret Tempero

hope private insurers will follow suit. The other niggling issue here is that, without a doubt, we will find molecular abnormalities in tumors that reflect germline mutations. This obviously leads to the need for genetic counseling and germline testing

Full access

germline testing in patients with cancer and wondering how in the world you might automate genetic counseling to accommodate it. This conversation got me thinking about what might already be available for patients with cancer, and I immediately thought

Full access

they relate to individuals with a personal or family history. The extensive update includes a clarified step-by-step process for the assessment of hereditary CRC syndromes, and a greater emphasis on the importance of genetic counseling. “Many of these

Full access

Peter H. Carroll and James L. Mohler

men with high-risk, very high-risk, regional, or metastatic prostate cancer. Men with BRCA1 /2, ATM, PALB2 , or FANCA should be referred for genetic counseling and early use of platinum chemotherapy, or consider enrollment on a clinical trial. 2

Full access

Robert W. Carlson

and supportive care topics. For example, this special edition includes a presentation on “Genetic Counseling in Patients with Familial Risk for Colorectal Cancer,” a topic that was translated into new NCCN Guidelines for Genetic/Familial High

Full access

Mary B. Daly, Robert Pilarski, Jennifer E. Axilbund, Saundra S. Buys, Beth Crawford, Susan Friedman, Judy E. Garber, Carolyn Horton, Virginia Kaklamani, Catherine Klein, Wendy Kohlmann, Allison Kurian, Jennifer Litton, Lisa Madlensky, P. Kelly Marcom, Sofia D. Merajver, Kenneth Offit, Tuya Pal, Boris Pasche, Gwen Reiser, Kristen Mahoney Shannon, Elizabeth Swisher, Nicoleta C. Voian, Jeffrey N. Weitzel, Alison Whelan, Georgia L. Wiesner, Mary A. Dwyer, and Rashmi Kumar

emphasized that these guidelines were not developed as a substitute for professional genetic counseling. Rather, they are intended to serve as a resource for health care providers to identify individuals who may benefit from cancer risk assessment and genetic